During the past decade, VA Medical Center, Huntington conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "VA Medical Center, Huntington" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "Sanofi-Synthelabo" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "VA Medical Center, Huntington" are "Atherosclerosis" (1 trials), "Healthy" (1 trials), "Heart Failure" (1 trials), "Hypertension" (1 trials) and "Metformin" (1 trials). Many other conditions were trialed in "VA Medical Center, Huntington" in a lesser frequency.

Most popular intervention types in "VA Medical Center, Huntington" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "Chlorthalidone" (1 trials), "Clopidogrel 75" (1 trials), "Hydrochlorothiazide (HCTZ)" (1 trials) and "Metformin XR" (1 trials). Other intervention names were less common.

The vast majority of trials in "VA Medical Center, Huntington" are 3 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "VA Medical Center, Huntington". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in VA Medical Center, Huntington, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in VA Medical Center, Huntington, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".